logo

For the Inventor, By the Inventor

Bay Village, OH, United States of America

James G Phillips

This inventor holds 13 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Gliatech, Inc., The Cleveland Clinic Foundation, Chiron Corporation. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James G Phillips. Retrieved from https://idiyas.com/inventor/james-g-phillips

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Bay Village, OH (US) (1997 - 2019)
  • Cleveland, OH (US) (2018 - 2024)

Company Filing History:

goldMedal6 out of 17 
 
Gliatech, Inc.
 patents
silverMedal6 out of 1,074 
 
The Cleveland Clinic Foundation
 patents
bronzeMedal1 out of 672 
 
Chiron Corporation
 patents
4. 1 out of 358 
 
Glaxosmithkline LLC
 patents
where one patent can have more than one assignee

Years Active: 1997-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12741933 - Small molecule nicotinamide adenine dinucleotide modulators (2026-09-22),
2. 12649734 - Bioavailable protein disulfide isomerase inhibitors (2026-06-09),
3. 11865104 - Antitumor TET2 modulating compounds (2024-01-09),
4. 10370373 - Antitumor derivatives for differentiation therapy (2019-08-06),
5. 9926326 - Substituted thioxanthenone autophagy inhibitors (2018-03-27),
6. 9926316 - Antitumor derivatives for differentiation therapy (2018-03-27),
7. 7368453 - Quinazolinone compounds with reduced bioaccumulation (2008-05-06),
8. 6448282 - 1H-4(5)-substituted imidazole derivatives (2002-09-10),
9. 6166060 - 1H-4(5)-substituted imidazole derivatives (2000-12-26),
10. 6072057 - 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 (2000-06-06),
11. 6008240 - 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives (1999-12-28),
12. 5990317 - 2-(1H-4(5)-imidazoyl) cyclopropyl compounds (1999-11-23),
13. 5652258 - 2-(4-imidazoyl) cyclopropyl derivatives (1997-07-29),

Title: The Innovative Contributions of James G. Phillips

Introduction

James G. Phillips is a notable inventor based in Bay Village, Ohio, with a remarkable portfolio of 11 patents. His work primarily focuses on advancements in cancer treatment, showcasing his commitment to improving healthcare through innovative solutions.

Latest Patents

Among his latest patents, Phillips has developed antitumor TET2 modulating compounds. This method of treating cancer involves administering a therapeutically effective amount of a TET2 activating compound or its pharmaceutically acceptable salt to a subject in need of treatment. The TET2 activating compounds are identified as α-ketoglutarate derivatives. Additionally, he has described a method for treating or preventing cancer that includes analyzing a biological sample to determine if cells exhibit a TET2 mutation, alongside administering a TET2 activator. Another significant patent involves antitumor derivatives for differentiation therapy, specifically imidazopyridine derivatives according to a defined formula.

Career Highlights

Throughout his career, Phillips has made significant contributions to the field of medical research. He has worked with esteemed organizations such as Gliatech, Inc. and The Cleveland Clinic Foundation, where he has been able to apply his innovative ideas to real-world challenges in healthcare.

Collaborations

Phillips has collaborated with notable colleagues, including Clark E. Tedford and Amin Mohammed Khan, further enhancing the impact of his work through teamwork and shared expertise.

Conclusion

James G. Phillips exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. His patents and collaborations reflect a dedication to advancing healthcare solutions that can significantly benefit patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…